127 related articles for article (PubMed ID: 7657594)
1. Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding.
Cunningham SA; Waxham MN; Arrate PM; Brock TA
J Biol Chem; 1995 Sep; 270(35):20254-7. PubMed ID: 7657594
[TBL] [Abstract][Full Text] [Related]
2. Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system.
Lamothe B; Bucchini D; Jami J; Joshi RL
FEBS Lett; 1995 Oct; 373(1):51-5. PubMed ID: 7589433
[TBL] [Abstract][Full Text] [Related]
3. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.
Nishimura R; Li W; Kashishian A; Mondino A; Zhou M; Cooper J; Schlessinger J
Mol Cell Biol; 1993 Nov; 13(11):6889-96. PubMed ID: 7692233
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells.
Serve H; Hsu YC; Besmer P
J Biol Chem; 1994 Feb; 269(8):6026-30. PubMed ID: 7509796
[TBL] [Abstract][Full Text] [Related]
5. Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase binding.
Yu Y; Hulmes JD; Herley MT; Whitney RG; Crabb JW; Sato JD
Biochem J; 2001 Sep; 358(Pt 2):465-72. PubMed ID: 11513746
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain.
Antonetti DA; Algenstaedt P; Kahn CR
Mol Cell Biol; 1996 May; 16(5):2195-203. PubMed ID: 8628286
[TBL] [Abstract][Full Text] [Related]
7. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
Dombrosky-Ferlan PM; Corey SJ
Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
[TBL] [Abstract][Full Text] [Related]
8. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
Barleon B; Totzke F; Herzog C; Blanke S; Kremmer E; Siemeister G; Marmé D; Martiny-Baron G
J Biol Chem; 1997 Apr; 272(16):10382-8. PubMed ID: 9099677
[TBL] [Abstract][Full Text] [Related]
9. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
[TBL] [Abstract][Full Text] [Related]
10. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
Susa M; Rohner D; Bichsel S
Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
[TBL] [Abstract][Full Text] [Related]
11. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
Soker S; Fidder H; Neufeld G; Klagsbrun M
J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
[TBL] [Abstract][Full Text] [Related]
12. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites.
Cunningham SA; Arrate MP; Brock TA; Waxham MN
Biochem Biophys Res Commun; 1997 Nov; 240(3):635-9. PubMed ID: 9398617
[TBL] [Abstract][Full Text] [Related]
13. p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells.
Zhang S; Broxmeyer HE
Biochem Biophys Res Commun; 1999 Jan; 254(2):440-5. PubMed ID: 9918857
[TBL] [Abstract][Full Text] [Related]
14. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways.
Zeng H; Dvorak HF; Mukhopadhyay D
J Biol Chem; 2001 Jul; 276(29):26969-79. PubMed ID: 11350975
[TBL] [Abstract][Full Text] [Related]
15. A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression.
Morishita K; Johnson DE; Williams LT
J Biol Chem; 1995 Nov; 270(46):27948-53. PubMed ID: 7499271
[TBL] [Abstract][Full Text] [Related]
16. In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.
Ottinger EA; Hui TY; Man Z; Barany G; Bernlohr DA
Int J Pept Protein Res; 1995 Nov; 46(5):346-53. PubMed ID: 8567177
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2.
Igarashi K; Isohara T; Kato T; Shigeta K; Yamano T; Uno I
Biochem Biophys Res Commun; 1998 May; 246(1):95-9. PubMed ID: 9600074
[TBL] [Abstract][Full Text] [Related]
18. The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis.
Kontos CD; Cha EH; York JD; Peters KG
Mol Cell Biol; 2002 Mar; 22(6):1704-13. PubMed ID: 11865050
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system.
Tartare-Deckert S; Murdaca J; Sawka-Verhelle D; Holt KH; Pessin JE; Van Obberghen E
Endocrinology; 1996 Mar; 137(3):1019-24. PubMed ID: 8603569
[TBL] [Abstract][Full Text] [Related]
20. Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit.
Rordorf-Nikolic T; Van Horn DJ; Chen D; White MF; Backer JM
J Biol Chem; 1995 Feb; 270(8):3662-6. PubMed ID: 7876105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
